YDES NASDAQ
YD Bio Limited Ordinary Shares
1W: +41.5%
1M: +115.7%
3M: +246.6%
YTD: -32.4%
1Y: -54.7%
$8.11
+0.30 (+3.84%)
Weekly Expected Move ±33.0%
$3
$5
$8
$11
$13
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-3200.2% ▼
Capital Expenditures
$3M
-1003691.0% ▼
4Y CAGR: +2662.3%
Free Cash Flow
-$5M
-8386.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3M
+5246.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | $9M | $4M | $14K | -$1M |
| Depreciation & Amort. | $0 | $0 | $0 | $2K | $105K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $90K | $632K | -$697K | -$127K | -$568K |
| Other Non-Cash Items | $2M | -$10M | -$6M | $51K | $11K |
| Operating Cash Flow | -$254K | -$688K | -$3M | -$56K | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$290 | -$75K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$117M | -$1M | -$1M | -$529K | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $10K |
| Other Investing | $0 | $0 | $102M | $529K | -$3M |
| Investing Cash Flow | -$117M | -$1M | $100M | -$290 | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $1M | $4M | -$33K | -$33K |
| Stock Repurchased | $0 | $0 | -$102M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $94K | -$100K |
| Financing Cash Flow | $118M | $1M | -$97M | $114K | $8M |
| Net Change in Cash | $694K | -$688K | $9K | $57K | $3M |
| Cash End of Period | $694K | $5K | $14K | $87K | $3M |
| Free Cash Flow | -$254K | -$688K | -$3M | -$56K | -$5M |